SHELBY LEA LAUGHLIN
Allopathic & Osteopathic Physicians|Family Medicine OZARK, MO NPI 1821659699
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine MO Lilly USA, LLC All categories
General Payments — all program years on this page
$1,902.55
- Category: General Payments
- Program years: PY2019–2024
- Record count: 117
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $800.61 across 44 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $800.61 | 44 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $104.44 | 6 |
| Novo Nordisk AS | $83.70 | 5 |
| Abbott Laboratories | $71.08 | 3 |
| Phathom Pharmaceuticals, Inc. | $68.00 | 3 |
| Otsuka America Pharmaceutical, Inc. | $53.30 | 3 |
| DEXCOM, INC. | $52.48 | 2 |
| Axsome Therapeutics, Inc. | $48.01 | 2 |
| GlaxoSmithKline, LLC. | $47.73 | 3 |
| PFIZER INC. | $47.60 | 3 |
| ABBVIE INC. | $35.24 | 2 |
| EISAI INC. | $34.66 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.83 | 2 |
| IDORSIA PHARMACEUTICALS US INC | $21.74 | 1 |
| Amgen Inc. | $17.33 | 1 |
| Medtronic, Inc. | $16.24 | 1 |
| Exact Sciences Corporation | $15.45 | 1 |
| Lundbeck LLC | $15.11 | 1 |
| Merck Sharp & Dohme Corporation | $15.09 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.38 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.20 | 1 |
By program year
Records — PY2024 (44)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.